George Ng Insider Profile
4 Followers
George Ng, CEO, Director at Processa Pharmaceuticals, holds 21.38K shares in Processa Pharmaceuticals (Ticker: PCSA), holds ― shares in TuHURA Biosciences (Ticker: HURA), holds 407.94K shares in Sorrento Therapeutics (Ticker: SRNE).
George Ng Processa Pharmaceuticals (PCSA)CEO, Director
Processa Pharmaceuticals (PCSA)
CEO, Director
Ranked #103,607 out of 108,699 Corporate Insiders
Profitable Transactions
1 out of 13 Profitable Transactions
Average Return
-38.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that George Ng holds in companies
Most Profitable Insider Trade
The most profitable trade made by George Ng
George Ng's Trading History
Processa Pharmaceuticals
Aug 11, 2026
CEO, Director
Uninformative Buy
4.11K
$45.11K
TuHURA Biosciences
―
Director
―
―
Sorrento Therapeutics
Feb 28, 2018
EVP, Chief Administrative Officer & Chief Legal Of
Uninformative Buy
―
―
List of latest transactions for each holding click on a transaction to see George Ng's performance on stock
You May Also Like
George Ng insider profile FAQ
What is the percentage of profitable transactions made by George Ng?
The percentage of profitable transactions made by George Ng is 8%.
What is the average return per transaction made by George Ng?
The average return per transaction made by George Ng is -38.40%.
What stocks does George Ng hold?
George Ng holds: PCSA, HURA, SRNE stocks.
What was George Ng’s latest transaction?
George Ng latest transaction was an Uninformative Buy of $4.11K.
What was George Ng's most profitable transaction?
George Ng’s most profitable transaction was an Informative Buy of PCSA stock on July 1, 2026. The return on the trade was 6.10%.
What is George Ng's role in Processa Pharmaceuticals?
George Ng's role in Processa Pharmaceuticals is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.